Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Declage (SR-hGH) in Adults with Growth Hormone Deficiency
NCT01605331Phase 4Completed
- Sponsor
- LG Chem
- Start
- Dec 2009
- Primary completion
- Sep 2010
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 4 trial of Eutropin Plus in growth hormone deficiency (GHD), sponsored by LG Chem. Started Dec 2009; status: completed.
02
Drugs
Eutropin Plus
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01605331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01605331.